Quantum Genomics publishes its results for fiscal 2021
and gives an update on its activity
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the
Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity Firibastat expected to launch in late 2023 for difficult-to-treat/resistant hypertension. Gross cash of €24.9
Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity Firibastat expected to launch in late 2023 for difficult-to-treat/resistant hypertension. Gross cash. | October 6, 2021
Quantum Genomics Reports Full Year 2020 Operating and Financial Results globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.